• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency.

作者信息

Spernovasilis Nikolaos, Agouridis Aris P, Tsioutis Constantinos

机构信息

Department of Infectious Diseases, German Oncology Center, Limassol, Cyprus; School of Medicine, University of Crete, Heraklion, Greece.

School of Medicine, European University Cyprus, Nicosia, Cyprus; Department of Internal Medicine, German Oncology Center, Limassol, Cyprus.

出版信息

Lancet Microbe. 2023 May;4(5):e293. doi: 10.1016/S2666-5247(23)00061-7. Epub 2023 Mar 15.

DOI:10.1016/S2666-5247(23)00061-7
PMID:36933564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10017110/
Abstract
摘要

相似文献

1
Appropriate antimicrobial use during the COVID-19 pandemic: not cause for complacency.2019冠状病毒病大流行期间的抗菌药物合理使用：不可掉以轻心。
Lancet Microbe. 2023 May;4(5):e293. doi: 10.1016/S2666-5247(23)00061-7. Epub 2023 Mar 15.
2
Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.2020 年日本的抗菌药物使用量大幅下降——新冠疫情可能发挥了作用。
Int J Infect Dis. 2022 Jun;119:13-17. doi: 10.1016/j.ijid.2022.03.019. Epub 2022 Mar 17.
3
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)-authors' response.全球抗菌药物消费：世界卫生组织《全球抗菌药物耐药性行动计划》及2019冠状病毒病（COVID-19）大流行的影响——作者回应
J Antimicrob Chemother. 2022 Sep 30;77(10):2889-2890. doi: 10.1093/jac/dkac274.
4
Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D.利用《国际大流行防范创新条约》重振抗菌药物研发创新生态系统。
J Law Med Ethics. 2022;50(S2):47-54. doi: 10.1017/jme.2022.79.
5
Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients.COVID-19 患者和非 COVID-19 患者的抗菌药物消耗和药物利用模式。
J Antimicrob Chemother. 2023 Mar 2;78(3):840-849. doi: 10.1093/jac/dkad025.
6
Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns.新冠疫情期间瑞典的抗菌药物使用情况：处方配药和住院患者医疗需求申请模式。
BMC Infect Dis. 2022 May 24;22(1):492. doi: 10.1186/s12879-022-07405-3.
7
Management of orofacial lesions with antimicrobial photodynamic therapy and photobiomodulation protocols in patients with COVID-19: A multicenter case series.COVID-19患者口腔颌面部病变的抗菌光动力疗法和光生物调节方案治疗：一项多中心病例系列研究
Photodiagnosis Photodyn Ther. 2022 Jun;38:102743. doi: 10.1016/j.pdpdt.2022.102743. Epub 2022 Jan 31.
8
Frontiers in Antimicrobial Materials.抗菌材料前沿。
Int J Mol Sci. 2022 Jul 21;23(14):8047. doi: 10.3390/ijms23148047.
9
Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective.阐述 COVID-19 对抗菌药物耐药性的影响：印度视角。
Sci Total Environ. 2022 Apr 20;818:151702. doi: 10.1016/j.scitotenv.2021.151702. Epub 2021 Nov 16.
10
Outpatient parenteral antimicrobial therapy (OPAT) from an emergency model applied during the COVID-19 pandemic to standard of care: Preliminary lessons from our experience.COVID-19 大流行期间应用的急诊模式下的门诊患者的抗菌药物治疗（OPAT）转为标准治疗：我们经验中的初步教训。
Infect Dis Now. 2023 Mar;53(2):104642. doi: 10.1016/j.idnow.2023.01.002. Epub 2023 Jan 13.

引用本文的文献

1
Not surprising: a rebound in antibacterial consumption in Europe, with Cyprus and Greece on the podium.毫不奇怪：欧洲的抗菌药物消费出现反弹，塞浦路斯和希腊位居前列。
J Antimicrob Chemother. 2024 May 2;79(5):933-934. doi: 10.1093/jac/dkae055.
2
Antibiotics and Lipid-Modifying Agents: Potential Drug-Drug Interactions and Their Clinical Implications.抗生素与调脂药物：潜在的药物相互作用及其临床意义。
Pharmacy (Basel). 2023 Aug 19;11(4):130. doi: 10.3390/pharmacy11040130.
3
Assessing the impact of antimicrobial stewardship implementation at a district hospital in Ghana using a health partnership model.利用健康伙伴关系模式评估加纳一家区级医院抗菌药物管理实施的影响。
JAC Antimicrob Resist. 2023 Jul 17;5(4):dlad084. doi: 10.1093/jacamr/dlad084. eCollection 2023 Aug.